- Training
- 60 Minutes
United States
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 75 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
United States
- Training
- 60 Minutes
Global
- Training
- 2 Hours
Global
- Webinar
- May 2023
- 180 Minutes
Global
From €309EUR$340USD£265GBP
- Webinar
- May 2023
- 90 Minutes
Global
From €173EUR$190USD£148GBP
- Webinar
- May 2023
- 240 Minutes
Europe
From €451EUR$495USD£386GBP
- Webinar
- June 2022
- 240 Minutes
Global
From €451EUR$495USD£386GBP
- Webinar
- 90 Minutes
Global
From €173EUR$190USD£148GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global

The CGMP market is a subset of the pharmaceutical manufacturing industry, focusing on the production of drugs and other pharmaceutical products in accordance with Current Good Manufacturing Practices (CGMP). CGMPs are a set of regulations and guidelines issued by the US Food and Drug Administration (FDA) to ensure that pharmaceutical products are safe and effective. CGMPs cover all aspects of the manufacturing process, from raw materials to finished products, and include requirements for quality control, personnel training, and record keeping.
The CGMP market is highly competitive, with many large and small companies offering a variety of services. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Teva Pharmaceuticals, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more